Author

Cecile P. G. Meier-Scherling

Observed names: Cecile Meier-Scherling, Cecile Meier-Sherling, Cecile P G Meier-Scherling, Cecile P.G. Meier-Scherling, Cécile P G Meier-Scherling, Cécile P. G. Meier-Scherling

Institution: Brown University

Observed institution: Brown University

ORCID: 0000-0002-7833-5164

Observed ORCID: 0000-0002-7833-5164

OpenAlex ID: A5093858059

Selection of Plasmodium falciparum kelch13 mutations in Uganda in comparison with southeast Asia: a modelling study

2025 · Cecile P G Meier-Scherling, Oliver J Watson, et al. · The Lancet Microbe · 14

Selection of Artemisinin Partial Resistance Kelch13 Mutations in Uganda in 2016-22 Was at a Rate Comparable to that Seen Previously in South-East Asia

2024 · Cecile P. G. Meier-Scherling, Oliver J Watson, et al. · medRxiv · 14

PDF

Risk of selection and timelines for the continued spread of artemisinin and partner drug resistance in Africa

2024 · Oliver J. Watson, Salome Muchiri, et al. · medRxiv · 5

Toward Setting Minimum and Optimal Data to Report for Malaria Molecular Surveillance with Targeted Sequencing: The “What” and “Why”

2025 · Jonathan Juliano, Cecile Meier-Scherling, et al. · American Journal of Tropical Medicine and Hygiene · 3

Mapping the prevalence of molecular markers of Plasmodium falciparum artemisinin partial resistance in Africa: a systematic review and spatiotemporal modelling study

2026 · Neeva Wernsman Young, Cécile P G Meier-Scherling, et al. · The Lancet Infectious Diseases · 1

Characterizing clinical toxicity in cancer combination therapies

2026 · Alexandra M Wong, Cecile P G Meier-Scherling, et al. · Bioinformatics · 1

PDF

Mapping the prevalence of molecular markers of Plasmodium falciparum artemisinin partial resistance in Africa: a spatial-temporal modelling study

2025 · Neeva Wernsman Young, Cécile P. G. Meier-Scherling, et al. · medRxiv · 1

Comparison and interpretability of machine learning algorithms to predict survival of patients with prostate cancer

2026 · Isaac E. Kim, Cecile P.G. Meier-Scherling, et al. · Urologic Oncology Seminars and Original Investigations

Abstract 1422: Characterizing clinical toxicity in cancer combination therapies.

2026 · Alexandra M. Wong, Cecile Meier-Scherling, et al. · Cancer Research

amw14/toxicity-cancer-drug-combination: Primary Release of CCTCCT

2026 · Alex Wong, Cecile Meier-Scherling, et al. · Zenodo (CERN European Organization for Nuclear Research)

Works count: 10

Citation count: 39

H-index: 3

I10-index: 2